Skip to main content
OpenTrials
Completed

NCT Number: NCT01518218

Effectiveness of Laying-on-of-hands for Sickle Cell Disease

The objective of this study is to evaluate the effectiveness of 1-year administration of laying-on-of-hands on the morbidity and mortality of patients with sickle cell disease in Africa.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sickle Cell Disease Anemia Anemia, Hemolytic Anemia, Hemolytic, Congenital Anemia, Sickle Cell Congenital, Hereditary, and Neonatal Diseases and Abnormalities Death Genetic Diseases, Inborn Hematologic Diseases Hemic and Lymphatic Diseases Hemoglobinopathies Infection Infections Pain Crisis Recurrent Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

3 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

The national medical center for sickle cell disease

Kinshasa, Democratic Republic of the Congo

About this study

Patients with sickle cell disease (SCD) have a high risk of premature death in Africa, mainly due to insufficient medical services. SCD patients often visit emergency department and need hospitalization when they suffer from severe pain; however, they manage most of painful episodes at home. Appropriate pain management at home is, therefore, crucial to improve their clinical course and quality of life. Laying-on-of-hands may be a good candidate for home care management, because family member(s) can become a practitioner of laying-on-of-hands without difficulty and administer it to their loved one as an initial treatment whenever necessary. There are no reports concerning the effectiveness of laying-on-of-hands for the outcomes of SCD patients, as far as we have investigated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with symptoms associated with sickle cell disease
  • those able to receive laying-on-of-hands every weekday for 1 year
  • those able to receive conventional medical treatment whenever necessary
  • those able to receive blood test at the beginning, after 6 month and after 1 year

Exclusion criteria

  • those who wish to use other complementary and alternative therapies along with laying-on-of-hands

Treatment and study plan

laying-on-of-hands

Behavioral

The intervention group received laying-on-of-hands every weekday for 1 year along with conventional medicine. The control group did not undergo any alternatives to OPT.

Other names: Okada Purifying Therapy, biofield therapy

Primary outcomes

  1. disease-related episodes and mortality

    Time frame: 3 years and 9 months

Secondary outcomes

  1. blood data

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

MOA Health Science Foundation

Other

Registry information

Official study title

Effectiveness of Laying-on-of-hands for Patients With Sickle Cell Disease in Africa

Important dates

Study start
2006
Primary completion
2007
Study completion
2009
First posted
Jan 25, 2012
Registry last updated
Apr 13, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.